News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
258 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17551)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (183)
2 (133)
5 (258)
6 (198)
7 (182)
8 (148)
9 (107)
12 (179)
13 (165)
14 (166)
15 (167)
16 (111)
19 (154)
20 (181)
21 (149)
22 (151)
23 (144)
26 (176)
27 (154)
28 (138)
29 (167)
30 (89)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
Drug Development
APHINITY Study Shows Genentech’s Perjeta-Based Regimen Reduced The Risk Of Invasive Cancer Returning Compared To Herceptin And Chemotherapy In HER2-Positive Early Breast Cancer
June 5, 2017
·
1 min read
Drug Development
MabVax Therapeutics Phase I Trial Results Of Antibody Therapy MVT-5873 For The Treatment Of Advanced Pancreatic Cancer Presented At The 2017 ASCO Annual Meeting
June 5, 2017
·
7 min read
Business
Thermo Fisher Scientific And Biognosys Announce Co-Marketing Agreement To Create Industry-Leading Data-Independent Acquisition Workflows
June 5, 2017
·
3 min read
Drug Development
Zavante Therapeutics Presents Positive Results From NIH-Sponsored ZOLYD Phase I Trial At ASM Microbe 2017 Meeting
June 5, 2017
·
6 min read
Drug Development
Boehringer Ingelheim Release: Encouraging Phase II Survival Data For Oral Nintedanib In Malignant Pleural Mesothelioma Presented At ASCO 2017
June 5, 2017
·
5 min read
Drug Development
Sierra Oncology Reports Encouraging Initial Progress From Ongoing Phase I Clinical Trials Of Chk1 Inhibitor SRA737
June 5, 2017
·
10 min read
Drug Development
Forge Therapeutics And Evotec AG Present First Efficacy Data For LpxC Inhibitor In UTI Model At ASM Microbe 2017
June 5, 2017
·
3 min read
Drug Development
AbbVie Release: Long-Term IMBRUVICA (ibrutinib) Efficacy And Safety Data At ASCO 2017 Show Sustained Survival Rates In Up To Four Years In Previously-Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Patients, Including Those With
June 5, 2017
·
14 min read
Zenith Technologies Announces Issuance Of Patent For ZEN-3694 And Presentation Details At BIO International Convention
June 5, 2017
·
1 min read
AstraZeneca PLC’s Cancer Gamble Bears Fruit as Lynparza Stays One Step Ahead of PARP Rivals
June 5, 2017
·
7 min read
Previous
5 of 26
Next